| Scrip Code | 524370 |
|---|---|
| NSE Symbol | BODALCHEM |
| MSEI Symbol | NOTLISTED |
| ISIN | INE338D01028 |
| Name of company | Bodal Chemicals Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 12-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 05-11-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | In line with Ind AS - 108 – “Operating Segments”, the operations of the Company fall under Chemical Business which is considered to be the only reportable business segment. |
| Start date and time of board meeting | 12-11-2025 12:42:00 |
| End date and time of board meeting | 12-11-2025 13:45:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 48,045.20 | 93,465.50 | |
| Other income | 1,992.60 | 2,397.50 | |
| Total income | 50,037.80 | 95,863.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 24,247.70 | 46,975.20 |
| (b) | Purchases of stock-in-trade | 498.50 | 981.90 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 2,665.80 | 3,208.20 |
| (d) | Employee benefit expense | 3,214.20 | 6,367.60 |
| (e) | Finance costs | 1,991.50 | 4,154.70 |
| (f) | Depreciation, depletion and amortisation expense | 1,741.50 | 3,492.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 14,931.50 | 28,539.80 |
| 2 | Loss arising from Company's Subsidiary operating in hyperinflationary economies [Refer Note 7] | 188.90 | 333.40 |
| Total other expenses | 15,120.40 | 28,873.20 | |
| Total expenses | 49,479.60 | 94,052.80 | |
| 3 | Total profit before exceptional items and tax | 558.20 | 1,810.20 |
| 4 | Exceptional items | (3.00) | (3.00) |
| 5 | Total profit before tax | 555.20 | 1,807.20 |
| 6 | Tax expense | ||
| 7 | Current tax | 2.60 | 7.10 |
| 8 | Deferred tax | (46.70) | 247.50 |
| 9 | Total tax expenses | (44.10) | 254.60 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 599.30 | 1,552.60 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 599.30 | 1,552.60 |
| 17 | Other comprehensive income net of taxes | (190.40) | (221.70) |
| 18 | Total Comprehensive Income for the period | 408.90 | 1,330.90 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 599.30 | 1,552.60 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 408.90 | 1,330.90 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2,518.90 | 2,518.90 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.47 | 1.23 | |
| Diluted earnings (loss) per share from continuing operations | 0.47 | 1.23 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.47 | 1.23 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.47 | 1.23 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Notes on unaudited consolidated financial results: 1 The above unaudited consolidated financial results have been reviewed and considered by the Audit Committee and subsequently approved by the Board of Directors at their respective meetings held on 12th November 2025. 2 The statutory auditors have carried out Limited Review of the above results as per Regulation 33 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015. 3 The consolidated financial results are prepared in accordance with principles and procedures as set out in the IND AS 110 Consolidated financial statements” prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued there under. The consolidated financial results include financial results of the following entities: i. Bodal Chemicals Limited – Parent ii. Bodal Chemicals Trading Pvt. Ltd.-Wholly Owned Subsidiary iii. Bodal Chemicals Trading (Shijiazhuang) Co., Ltd. -Wholly Owned Subsidiary iv. Sener Boya Kimya Tekstil Sanayi Ve Ticaret Anonim Sirketi – Subsidiary v. Bodal Bangla Ltd. - Wholly Owned Subsidiary vi. Senpa Dis Ticaret Anonim Sirketi - Step down subsidiary- (wholly owned subsidiary of Sener Boya Kimya Tekstil Sanayi Ve Ticaret Anonim Sirketi - Subsidiary) vii. Plutoeco Enviro Association - Associate Company viii. PT Bodal Chemicals Indonesia - Wholly Owned Subsidiary 4 These financial results have been prepared in accordance with the recognition and measurement principles of applicable Indian Accounting Standards ('Ind AS') notified under the Companies (Indian Accounting Standards) Rules, 2015 as specified in section 133 of the Companies Act, 2013 (read with SEBI Circular CIR/CFD/FAC/62/2016 dated 05 July 2016 and other recognised accounting practices and policies). 5 The group has changed the classification of an Item during the period for better presentation. The figures for the corresponding quarter and half have been regrouped/reclassified wherever necessary, to make them comparable. The detail thereof has been provided below. Statement of Profit & Loss Items (Rs. in Million) Sr. No Previous Year Class of Item Quarter Ended 30/09/2024 Half Year ended 30/09/2024 Nature of Reclassification 1 Other Income 34.89 34.89 State Incentive and Subsidy Income is reclassified to Revenue from Operations. 6 As disclosed in the financial results for the quarter and year ended March 31, 2025, a fire incident occurred in December 2024 at the blending operations area of the Dyes Plant at Unit 7, resulting in damage to inventories and certain property, plant and equipment. During current quarter, the Group received an insurance claim of Rs. 47.11 million against a total claim of Rs. 59.91 million. The balance amount of Rs. 12.80 million has been recognized as Loss due to Fire, out of which Rs. 12.50 million was booked in FY 2024-25, and the remaining amount of Rs. 0.30 million has been booked under Exceptional Items in the current quarter. The insurance claim has been fully settled. 7 The Group has applied Ind AS 29 - 'Accounting of Hyperinflationary economies' on its subsidiary and step-down subsidiary in Turkey. Turkish Lira is functional currency of the aforesaid subsidiaries in Turkey. In preparing the consolidated financial results for the half year ended September 30, 2025, the non-monetary assets/ liabilities/ owner's equity and statement of profit and loss of the aforesaid subsidiaries have been restated to the measuring unit current as on the reporting date by applying consumer price index of the Turkish economy. The net impact of the aforesaid restatement amounting to Rs.33.34 million and Rs. 18.89 million has been debited for the half year ended and quarter ended September 30, 2025 respectively, disclosed separately as it is a material item. Considering that the presentation currency of the Holding Company is INR, the restatement of comparative figures in consolidated financial results is not required. The impact of said restatements till March 31, 2025 in respect of the aforesaid subsidiaries amounting to Rs.38.56 million has been credited in the opening retained earnings as at April 1, 2025. 8 During the quarter, Group has sold part of Unit – II, located at Plot / Shed No. C1B/111 to 114, Phase - I, Vatva, G.I.D.C., Ahmedabad -382445. The said unit was inoperative and not generating any revenue since long and not a significant unit in terms of any other matters of the group. Above said unit i.e. UNIT II B, was already closed by the group and the same was intimated vide its letter number Sec/24-25/18 dated 24th May 2024. Profit on sale of this Unit of Rs. 106.60 million is included in Other Income of this quarter. 9 During the quarter, Group has sold Unit – III, located at Plot No: 2102, Phase-III, Vatva, G.I.D.C., Ahmedabad-382445. The said unit was inoperative and not generating any revenue since long and not a significant unit in terms of any other matters of the group. Above said unit i.e. UNIT III, was already closed by the group and the same was intimated vide its letter number Sec/24-25/18 dated 24th May 2024. Profit on sale of this Unit of Rs.72.34 million is included in Other Income of this Quarter. 10 In line with Ind AS - 108 – “Operating Segments”, the operations of the Group fall under Chemical Business which is considered to be the only reportable business segment. 11 The full financial results are also available on the stock exchanges' website i.e. www.bseindia.com and www.nseindia.com and on the Company’s website i.e. www.bodal.com |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 1,25,805.90 | |
| Capital work-in-progress | 796.30 | |
| Investment property | 6,132.30 | |
| Goodwill | 847.50 | |
| Other intangible assets | 353.70 | |
| Intangible assets under development | ||
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | ||
| Non-current financial assets | ||
| Non-current investments | 11.60 | |
| Trade receivables, non-current | ||
| Loans, non-current | 240.20 | |
| Other non-current financial assets | 5,603.90 | |
| Total non-current financial assets | 5,855.70 | |
| Deferred tax assets (net) | 2,567.40 | |
| Other non-current assets | 1,676.40 | |
| Total non-current assets | 1,44,035.20 | |
| 2 | Current assets | |
| Inventories | 29,647.20 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 43,989.40 | |
| Cash and cash equivalents | 1,550.30 | |
| Bank balance other than cash and cash equivalents | 1,408.90 | |
| Loans, current | 222.00 | |
| Other current financial assets | 950.80 | |
| Total current financial assets | 48,121.40 | |
| Current tax assets (net) | 198.60 | |
| Other current assets | 9,281.30 | |
| Total current assets | 87,248.50 | |
| 3 | Non-current assets classified as held for sale | 1.40 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 2,31,285.10 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 2,518.90 | |
| Other equity | 1,09,674.60 | |
| Total equity attributable to owners of parent | 1,12,193.50 | |
| Non controlling interest | 0.00 | |
| Total equity | 1,12,193.50 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 34,042.20 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| Total non-current financial liabilities | 34,042.20 | |
| Provisions, non-current | 105.40 | |
| Deferred tax liabilities (net) | 7,436.90 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | 670.80 | |
| Total non-current liabilities | 42,255.30 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 51,762.40 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 5,094.40 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 17,188.20 | |
| Total Trade payable | 22,282.60 | |
| Other current financial liabilities | 906.20 | |
| Total current financial liabilities | 74,951.20 | |
| Other current liabilities | 1,284.10 | |
| Provisions, current | 595.40 | |
| Current tax liabilities (Net) | 5.60 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 76,836.30 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 1,19,091.60 | |
| Total equity and liabilites | 2,31,285.10 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| Total Amount of items that will not be reclassified to profit and loss | |||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 19.10 | 42.60 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange differences in translating the financial statements of foreign subsidiaries | -17130000 | -17910000 |
| Total Amount of items that will be reclassified to profit and loss | (171.30) | (179.10) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | (190.40) | (221.70) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 1,807.20 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 4,154.70 | |||||
| Adjustments for decrease (increase) in inventories | 4,076.70 | |||||
| Adjustments for decrease (increase) in trade receivables, current | (3,986.70) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 1,390.20 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 201.70 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (1,372.60) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | (221.20) | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 3,492.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | (9.50) | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 268.40 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 62.60 | |||||
| Adjustments for dividend income | 0.10 | |||||
| Adjustments for interest income | 438.50 | |||||
| Adjustments for share-based payments | (7.70) | |||||
| Adjustments for fair value losses (gains) | 141.40 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | (1,660.90) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 6,090.50 | |||||
| Net cash flows from (used in) operations | 7,897.70 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 109.50 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 7,788.20 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 1,916.10 | |||||
| Proceeds from sales of investment property | 2,741.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 18.20 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.10 | |||||
| Interest received | 372.90 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (462.00) | |||||
| Net cash flows from (used in) investing activities | 754.10 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 637.00 | |||||
| Repayments of borrowings | 5,611.80 | |||||
| Payments of lease liabilities | 118.20 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 4,116.20 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 52.10 | |||||
| Net cash flows from (used in) financing activities | (9,157.10) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (614.80) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (179.00) | |||||
| Net increase (decrease) in cash and cash equivalents | (793.80) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 2,344.10 | |||||
| Cash and cash equivalents cash flow statement at end of period | 1,550.30 | |||||